A comprehensive map and functional annotation of the normal human cerebrospinal fluid proteome.

[1]  Yang Zhang,et al.  Data for a comprehensive map and functional annotation of the human cerebrospinal fluid proteome , 2015, Data in brief.

[2]  F. Berven,et al.  In-depth Characterization of the Cerebrospinal Fluid (CSF) Proteome Displayed Through the CSF Proteome Resource (CSF-PR)* , 2014, Molecular & Cellular Proteomics.

[3]  M. Brouwer,et al.  Cerebrospinal fluid complement activation in patients with pneumococcal and meningococcal meningitis. , 2014, The Journal of infection.

[4]  V. S. Wong,et al.  Complement Activation and Intraventricular Rituximab Distribution in Recurrent Central Nervous System Lymphoma , 2013, Clinical Cancer Research.

[5]  T. Ball,et al.  High pH reversed‐phase chromatography as a superior fractionation scheme compared to off‐gel isoelectric focusing for complex proteome analysis , 2013, Proteomics.

[6]  M. Ghosh,et al.  Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk. , 2013, Genes & cancer.

[7]  K. Aldape,et al.  Epidermal Growth Factor (EGF)-enhanced Vascular Cell Adhesion Molecule-1 (VCAM-1) Expression Promotes Macrophage and Glioblastoma Cell Interaction and Tumor Cell Invasion* , 2013, The Journal of Biological Chemistry.

[8]  Anushya Muruganujan,et al.  Large-scale gene function analysis with the PANTHER classification system , 2013, Nature Protocols.

[9]  Kelvin H. Lee,et al.  Targeted human cerebrospinal fluid proteomics for the validation of multiple Alzheimer's disease biomarker candidates. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  Y. Kodera,et al.  Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma , 2013, Molecular Cancer.

[11]  H. Soininen,et al.  iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia , 2012, Experimental Neurology.

[12]  D. Webb,et al.  Identification and proteomic profiling of exosomes in human cerebrospinal fluid , 2012, Journal of Translational Medicine.

[13]  Sheng Zhang,et al.  Evaluation of different multidimensional LC-MS/MS pipelines for isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomic analysis of potato tubers in response to cold storage. , 2011, Journal of proteome research.

[14]  B. Simons,et al.  Performance characteristics of a new hybrid quadrupole time-of-flight tandem mass spectrometer (TripleTOF 5600). , 2011, Analytical chemistry.

[15]  Akhilesh Pandey,et al.  A comprehensive map of the human urinary proteome. , 2011, Journal of proteome research.

[16]  M. Selbach,et al.  Global quantification of mammalian gene expression control , 2011, Nature.

[17]  T. MacDonald,et al.  Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study , 2011, Proteomics.

[18]  S. Wijmenga,et al.  Quantitative Proteomics and Metabolomics Analysis of Normal Human Cerebrospinal Fluid Samples* , 2010, Molecular & Cellular Proteomics.

[19]  Richard D. Smith,et al.  Establishing the Proteome of Normal Human Cerebrospinal Fluid , 2010, PloS one.

[20]  Jonas Bergquist,et al.  Assessment of the partitioning capacity of high abundant proteins in human cerebrospinal fluid using affinity and immunoaffinity subtraction spin columns. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[21]  Odile Burlet-Schiltz,et al.  In-depth Exploration of Cerebrospinal Fluid by Combining Peptide Ligand Library Treatment and Label-free Protein Quantification* , 2010, Molecular & Cellular Proteomics.

[22]  M. Dunn,et al.  Comparative analysis of OFFGel, strong cation exchange with pH gradient, and RP at high pH for first‐dimensional separation of peptides from a membrane‐enriched protein fraction , 2009, Proteomics.

[23]  M. Mann,et al.  Universal sample preparation method for proteome analysis , 2009, Nature Methods.

[24]  M. Gilbert,et al.  Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma , 2009, Journal of Neuro-Oncology.

[25]  Ling Lin,et al.  Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics , 2009, Trends in Neurosciences.

[26]  U. Hellman,et al.  Proteome Profiling of Human Cerebrospinal Fluid: Exploring the Potential of Capillary Electrophoresis with Surface Modified Capillaries for Analysis of Complex Biological Samples , 2008, European journal of mass spectrometry.

[27]  Sylvain Lehmann,et al.  Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers , 2008, Proteomics. Clinical applications.

[28]  Howard E Gendelman,et al.  Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment. , 2007, Journal of proteome research.

[29]  M. Blombäck,et al.  Coagulation abnormalities associated with severe isolated traumatic brain injury: cerebral arterio-venous differences in coagulation and inflammatory markers. , 2007, Journal of neurotrauma.

[30]  Dana Waichunas,et al.  Identification of glycoproteins in human cerebrospinal fluid with a complementary proteomic approach. , 2006, Journal of proteome research.

[31]  A. Fonteh,et al.  Protein Analysis in Human Cerebrospinal Fluid: Physiological Aspects, Current Progress and Future Challenges , 2005, Disease markers.

[32]  Eugene A. Kapp,et al.  Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database , 2005, Proteomics.

[33]  Jing Zhang,et al.  Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid , 2005, Neurobiology of Aging.

[34]  A. Sickmann,et al.  Towards a high resolution separation of human cerebrospinal fluid. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[35]  P. Verhaert,et al.  Identification of two‐dimensionally separated human cerebrospinal fluid proteins by N‐terminal sequencing, matrix‐assisted laser desorption/ionization — mass spectrometry, nanoliquid chromatography‐electrospray ionization‐time of flight‐mass spectrometry, and tandem mass spectrometry , 2000, Electrophoresis.

[36]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[37]  M. I. Rosa,et al.  Accuracy of cerebrospinal fluid Aβ(1-42) for Alzheimer's disease diagnosis: a systematic review and meta-analysis. , 2014, Journal of Alzheimer's disease : JAD.

[38]  Christophe Lemetre,et al.  Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid. , 2012, Journal of Alzheimer's disease : JAD.

[39]  M. Mann,et al.  Integrated analysis of the cerebrospinal fluid peptidome and proteome. , 2008, Journal of proteome research.

[40]  T. Montine,et al.  Characterization of proteome of human cerebrospinal fluid. , 2006, International review of neurobiology.

[41]  H. Kasuya,et al.  Activation of the coagulation system in the subarachnoid space after subarachnoid haemorrhage: Serial measurement of fibrinopeptide A and bradykinin of cerebrospinal fluid and plasma in patients with subarachnoid haemorrhage , 2005, Acta Neurochirurgica.